Definitive Contract 75A50122C00075

The U.S. Department of Health and Human Services, through its Office of the Assistant Secretary for Preparedness and Response, has awarded a $28,728,000.00 firm-fixed-price definitive contract to Princeton Biomeditech Corp (doing business as P B M) for the delivery of over-the-counter (OTC) COVID-19 tests. This contract, which has a completion date of March 19, 2025, does not utilize a set-aside designation. Princeton Biomeditech Corp is a manufacturer of rapid, point-of-care diagnostics,...

<p>The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $86,400,000.00 Firm Fixed Price definitive contract to Barupon LLC, a woman-owned small business, for the delivery of Over the Counter (OTC) COVID-19 tests. The contract has an ultimate completion date of March 19, 2025 and was awarded on September 20, 2023. No set-aside designation was used for this contract.</p>

This is a $748,027.21 firm fixed price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Senzo, Inc. for the development of a high-sensitivity, home-based, over-the-counter COVID-19 rapid diagnostic test. The contract was awarded under AOI #11A of ASPR's Division of Research, Innovation, and Ventures (DRIVe) Easy Broad Agency Announcement (EZ-BAA), which focuses on home-based diagnostics for SARS-CoV-2 detection. The contract has a period of...

The provided information describes a federal contract award by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Bioteke USA, LLC, a for-profit, woman-owned limited liability company. The contract is for the provision of over-the-counter COVID-19 tests and was awarded on September 27, 2024 with a ceiling value of $2,062,343.80. The contract is a definitive, firm fixed-price contract with a final completion date of March 26, 2026. This contract award...

<p>This is a $237,000,000.00 definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Osang LLC, a foreign-owned, self-certified small disadvantaged business. The purpose of the contract is to procure over-the-counter (OTC) COVID-19 tests. The contract does not have a set-aside designation and has a firm fixed-price pricing type with an ultimate completion date of April 7, 2023.</p>

<p>The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, has awarded a $4,500,000.00 firm-fixed-price definitive contract to Genabio Diagnostics Inc. for the provision of over-the-counter (OTC) COVID-19 tests. The contract, which is not set aside, has an ultimate completion date of March 19, 2025. This contract award appears to be a standalone acquisition and not part of a larger vehicle.</p>

This is a $49,536,000.00 firm fixed price definitive contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Maxim Biomedical, Inc., a small disadvantaged, woman-owned, Asian-Pacific American-owned business located in Rockville, Maryland. The contract is for the delivery of over-the-counter (OTC) COVID-19 tests with a period of performance through March 19, 2025. Maxim Biomedical has previously received other...

<p>This is a $31,384,584.00 firm fixed price definitive contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Kwell Laboratories LLC, a minority-owned small disadvantaged business, for the delivery of over-the-counter COVID-19 tests. The contract has an ultimate completion date of March 19, 2025. The contract is not set aside and was awarded on September 20, 2023.</p>

This is a $749,000.00 firm fixed price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to In Diagnostics, Inc. to develop endpoint and kinetic measurement capabilities on a low-cost, disposable spectrophotometer platform. The contract does not have a set-aside designation and is scheduled for completion by June 30, 2025. The awardee, In Diagnostics, Inc., is a for-profit organization located in Carlsbad, California.

This $34,714,763.00 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Detect Inc. to advance the development of a second-generation, multi-analyte molecular SARS-CoV-2 and influenza A/B test that has a reduced time to result and increased sensitivity for use at home or in a point-of-care setting. The contract is not set aside. The award references a Broad Agency Announcement (BAA) issued by the Biomedical Advanced Research...